[ad_1]
According to Zacks, "In the last three months, Monsanto shares have outperformed the Zacks agricultural products and products industry.The company announced better than expected results for the third quarter of the year. Fiscal 2017. Growing demand for crop yield enhancing products, stronger innovation, and the success of Bayer's buyout agreement should bolster Monsanto's performance in terms of net income and net income over the period. In the coming quarters, however, difficult pricing conditions in the agricultural market could limit growth in the short term, and headwinds such as the weaker currencies of major foreign markets, such as Brazil, or the rigid rivalry of the economy. Industry remain major sources of concern. "
Zacks Investment Research cut the shares of Monsanto Company (NYSE: MON) note in a note of rech published Tuesday morning.
Several other badysts also commented on MON. Royal Bank of Canada reaffirmed a sector performance rating and set a target price of $ 128.00 ($ 120.00) on Monsanto Company shares in a report on Thursday, June 29th. BidaskClub has updated Monsanto's company from a sales rating to a reservation rating in a research report on Thursday, June 29th. Barclays PLC increased its price target on Monsanto Company from $ 115.00 to $ 120.00 and badigned an equal weighting rating to the title in a research report on Thursday, June 29th. Vetr has upgraded Monsanto Company from a reservation rating to a purchase note and set a target price of $ 122.35 on the title in a research report on Tuesday, June 27. Finally, Susquehanna Bancshares Inc. reiterated a neutral rating and set a price target of $ 128.00 (previously $ 125.00) on Monsanto Company shares in a research report on Tuesday, June 27. An badyst rated the stock with a sales note, nine badigned a hold rating and ten gave a buy-to-action rating. The company currently has a consensual Hold rating and a consensus price target of $ 123.08
Monsanto Company (NYSE MON) opened at 117.61 on Tuesday. Monsanto Company has a 52-week low of $ 97.35 and a high of $ 118.87 over 52 weeks. The stock has a market capitalization of 51.67 billion, a capitalization ratio of 25.40 and a beta of 1.08. The 50-day weighted average price of the stock is $ 117.17 and its 200-day moving average price is $ 112.81.
Monsanto Company (NYSE: MON) reported its financial results for the last time on Wednesday, June 28. The base materials company posted earnings per share of $ 1.93 for the quarter, exceeding the consensus estimate of $ 1.74 per $ 0.19. The company achieved a turnover of $ 4.23 billion for the quarter, compared with badysts' estimates of $ 4.18 billion. Monsanto recorded a return on equity of 45.26% and a net margin of 14.11%. The Monsanto Company's sales figure for the quarter increased by 1.0% compared to the same quarter of last year. During the same period last year, the company earned $ 2.17 earnings per share. On average, equity badysts expect Monsanto Company to post earnings per share of $ 4.89 for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, July 28. Shareholders of record on Friday, July 7 will receive a dividend of $ 0.54 per share. The ex-dividend date is Wednesday, July 5th. This represents an annualized dividend of $ 2.16 and a return of 1.84%. The dividend payout ratio (DPR) of Monsanto Company is 46.75%.
Executive Vice President Steven Mizell sold 11,300 shares of Monsanto Company on Monday, July 3. The stock was sold at an average price of $ 118.57, for a total value of $ 1,339,841.00. As a result of the sale, the Executive Vice-President now holds directly 55,011 shares of the Company, valued at $ 6,522,654.27. The sale has been disclosed in a legal deposit with the Securities & Exchange Commission, which is available at this link. In addition, CEO Hugh Grant sold 149,230 shares of Monsanto Company on Monday, April 10. The shares were sold at an average price of $ 116.15, for a total value of $ 17,333,064.50. As a result of the sale, the CEO now holds directly 390,373 shares of the Company, valued at $ 45,341,823.95. The disclosure for this sale can be found here. In the last three months, insiders sold 277,276 shares valued at $ 32,258,748. 0.79% of the stock belongs to insiders.
Large investors have recently changed their equity holdings. The Swiss National Bank increased its stake in Monsanto Company shares by 25.6% in the first quarter. The Swiss National Bank now holds 1,676,066 shares in the commodity company valued at $ 189,731,000 after purchasing 341,400 additional shares in the last quarter. Kentucky Retirement Systems purchased a new equity interest in Monsanto Company during the fourth quarter valued at $ 3,344,000. Fisher Asset Management LLC has purchased a new equity interest in Monsanto Company during the first quarter worth $ 213,000. WFG Advisors LP increased its interest in Monsanto Company shares by 19.4% in the first quarter. WFG Advisors LP now holds 2,377 shares in the base materials company worth $ 269,000 after purchasing 387 additional shares in the last quarter. Finally, Goelzer Investment Management Inc. increased its stake in Monsanto Company shares by 1.2% in the first quarter. Goelzer Investment Management Inc. now holds 40,441 basic materials business shares valued at $ 4,578,000 after purchasing an additional 469 shares in the last quarter. 74.99% of the shares are held by institutional investors and hedge funds.
About Monsanto Company
Monsanto Company (Monsanto), with its subsidiaries, is a supplier of agricultural products to farmers. The company provides seeds, biotech products, herbicides and digital farming tools to farmers. The company operates in two segments: Seeds and Genomics, and Agricultural Productivity.
Get a free copy of the Zacks Research Report on Monsanto Company (MON)
For more information on Zacks Investment Research's research offerings, visit Zacks. com
Source link
